Gem Aromatics Limited has informed the Exchange about Transcript
GEMAROMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gem Aromatics reported Q4 FY26 standalone revenue of INR112 crore, up 34% sequentially from INR84 crore in Q3, though down year-on-year due to US tariff-related export uncertainty. Consolidated revenue was INR110 crore. Gross margins improved to 23.4% standalone and 30.5% consolidated, with EBITDA margins at 13.4% and 14.2% respectively. PAT stood at INR12 crore standalone, up 182% sequentially. The Dahej greenfield facility (Krystal Ingredients) is now fully live with INR260 crore of INR270 crore capex incurred; commercial production of Gemcool 5 and Safranal commenced in February 2026. Management guided FY28 consolidated revenue of ~INR1,100 crore with EBITDA margins of 16-18%, while explicitly refusing FY27 guidance citing geopolitical uncertainty and phenol raw material price volatility. Phenol-based derivatives production remains on hold pending raw material price stabilisation. The Silvassa plant received EcoVadis Platinum sustainability rating.
Sequential recovery in Q4 reflects improving business conditions, but management's refusal to give FY27 guidance due to geopolitical and raw material headwinds signals near-term uncertainty despite multi-year FY28 targets. Investors should monitor phenol derivative ramp-up and Dahej facility utilisation trajectory.